Tag

Khiron's Zerenia is to provide "Integrative Health Services and Pharmacotherapeutic Treatment with Medical Cannabis" to Capital Salud patients.

The 4,000 square foot facility features 11 patient rooms and according to Khiron, can handle 40,000 patient consultations per year.

Year to date medical cannabis prescriptions have exceeded 35,000 units, 600% more than the entire 2020 fiscal year. Khiron will expand its flagship clinic brand, Zerenia to the UK, with the first Zerenia opening in London in Q4 2021.

Hired in October 2019 to the role of Managing Director and Chief Legal Counsel, Khiron Europe, Katterbach's promotion to the position of President aligns with the company's commitment to diversity and inclusion throughout the organization, including at the executive level, the...

Khiron is now shipping its branded EU-GMP certified medical cannabis to Germany, providing immediate access to the German market through its distribution partner, Nimbus Health GmbH. Khiron teams continue to educate physicians with plans to leverage clinical evidence from both...

Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.

The UN body allocated 131,000 pounds of dried marijuana flower production to Colombia, 21.84% of the entire world total.